Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Intraoperative Binaural Sound on Remifentanil Dose Required for General Anesthesia Using Remimazolam: a Randomized, Placebo-controlled Trial

NCT06497283 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.

NCT NCT06497283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06497283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Intraoperative Binaural Sound on Remifentanil Dose Required for General Anesthesia Using Remimazolam: a Randomized, Placebo-controlled Trial
Lead sponsor
Gangnam Severance Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 12, 2024
Completion date
February 28, 2025
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

general anesthesia, prostate cancer stage, uterine myoma